company background image
PEB

Pacific Edge NZSE:PEB Stock Report

Last Price

NZ$0.47

Market Cap

NZ$368.6m

7D

4.4%

1Y

-65.2%

Updated

09 Dec, 2022

Data

Company Financials +
PEB fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

PEB Stock Overview

Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, Australia, and Singapore.

Pacific Edge Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Pacific Edge
Historical stock prices
Current Share PriceNZ$0.47
52 Week HighNZ$1.39
52 Week LowNZ$0.40
Beta0.90
1 Month Change8.05%
3 Month Change-6.00%
1 Year Change-65.19%
3 Year Change261.54%
5 Year Change32.39%
Change since IPO168.57%

Recent News & Updates

Companies Like Pacific Edge (NZSE:PEB) Are In A Position To Invest In Growth

Sep 06
Companies Like Pacific Edge (NZSE:PEB) Are In A Position To Invest In Growth

Recent updates

Companies Like Pacific Edge (NZSE:PEB) Are In A Position To Invest In Growth

Sep 06
Companies Like Pacific Edge (NZSE:PEB) Are In A Position To Invest In Growth

Pacific Edge (NZSE:PEB) Is In A Good Position To Deliver On Growth Plans

May 31
Pacific Edge (NZSE:PEB) Is In A Good Position To Deliver On Growth Plans

Pacific Edge (NZSE:PEB) Is In A Strong Position To Grow Its Business

Jan 17
Pacific Edge (NZSE:PEB) Is In A Strong Position To Grow Its Business

We're Hopeful That Pacific Edge (NZSE:PEB) Will Use Its Cash Wisely

Jun 05
We're Hopeful That Pacific Edge (NZSE:PEB) Will Use Its Cash Wisely

Pacific Edge Limited (NZSE:PEB): Are Analysts Optimistic?

May 14
Pacific Edge Limited (NZSE:PEB): Are Analysts Optimistic?

Don't Ignore The Fact That This Insider Just Sold Some Shares In Pacific Edge Limited (NZSE:PEB)

Mar 21
Don't Ignore The Fact That This Insider Just Sold Some Shares In Pacific Edge Limited (NZSE:PEB)

Did The Underlying Business Drive Pacific Edge's (NZSE:PEB) Lovely 750% Share Price Gain?

Mar 13
Did The Underlying Business Drive Pacific Edge's (NZSE:PEB) Lovely 750% Share Price Gain?

Have Insiders Been Selling Pacific Edge Limited (NZSE:PEB) Shares?

Feb 14
Have Insiders Been Selling Pacific Edge Limited (NZSE:PEB) Shares?

Pacific Edge Limited's (NZSE:PEB) Profit Outlook

Jan 18
Pacific Edge Limited's (NZSE:PEB) Profit Outlook

How Much Of Pacific Edge Limited (NZSE:PEB) Do Insiders Own?

Dec 23
How Much Of Pacific Edge Limited (NZSE:PEB) Do Insiders Own?

Did You Participate In Any Of Pacific Edge's (NZSE:PEB) Incredible 434% Return?

Nov 21
Did You Participate In Any Of Pacific Edge's (NZSE:PEB) Incredible 434% Return?

Shareholder Returns

PEBNZ BiotechsNZ Market
7D4.4%-0.6%-0.5%
1Y-65.2%-5.8%-14.1%

Return vs Industry: PEB underperformed the NZ Biotechs industry which returned -5.8% over the past year.

Return vs Market: PEB underperformed the NZ Market which returned -14.1% over the past year.

Price Volatility

Is PEB's price volatile compared to industry and market?
PEB volatility
PEB Average Weekly Movement6.7%
Biotechs Industry Average Movement8.7%
Market Average Movement4.2%
10% most volatile stocks in NZ Market6.7%
10% least volatile stocks in NZ Market2.9%

Stable Share Price: PEB is more volatile than 90% of NZ stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: PEB's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of NZ stocks.

About the Company

FoundedEmployeesCEOWebsite
2001100Peter Meintjeshttps://www.pacificedgedx.com

Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, Australia, and Singapore. It operates in two segments, Commercial and Research. The company offers Cxbladder, a genomic urine tests for the detection and management of bladder cancer.

Pacific Edge Limited Fundamentals Summary

How do Pacific Edge's earnings and revenue compare to its market cap?
PEB fundamental statistics
Market CapNZ$368.63m
Earnings (TTM)-NZ$21.37m
Revenue (TTM)NZ$16.48m

23.1x

P/S Ratio

-17.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
PEB income statement (TTM)
RevenueNZ$16.48m
Cost of RevenueNZ$7.89m
Gross ProfitNZ$8.59m
Other ExpensesNZ$29.96m
Earnings-NZ$21.37m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.026
Gross Margin52.13%
Net Profit Margin-129.70%
Debt/Equity Ratio0%

How did PEB perform over the long term?

See historical performance and comparison